The end of nandrolone.
Vergel
Nelson
N
D045930:Anabolic Agents / Q000600:supply & distribution* / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D004345:Drug Industry; D019247:HIV Wasting Syndrome / Q000188:drug therapy*; D006801:Humans; D009277:Nandrolone / Q000600:supply & distribution* / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D045930:Anabolic Agents; D009277:Nandrolone